These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 25026539)

  • 41. Clinical and electrophysiological features of peripheral neuropathy induced by administration of cisplatin plus paclitaxel-based chemotherapy.
    Argyriou AA; Polychronopoulos P; Koutras A; Xiros N; Petsas T; Argyriou K; Kalofonos HP; Chroni E
    Eur J Cancer Care (Engl); 2007 May; 16(3):231-7. PubMed ID: 17508942
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cisplatinum neuropathy with Lhermitte's sign.
    Kumar L; Kochupillai V; Kotwal PP
    J Assoc Physicians India; 1991 Sep; 39(9):715-6. PubMed ID: 1667659
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preventing chemotherapy-induced neuropathy.
    Nudleman KL
    West J Med; 1991 Jul; 155(1):70. PubMed ID: 1652176
    [No Abstract]   [Full Text] [Related]  

  • 44. Chemotherapy-Induced Peripheral Neuropathy.
    Brown TJ; Sedhom R; Gupta A
    JAMA Oncol; 2019 May; 5(5):750. PubMed ID: 30816956
    [No Abstract]   [Full Text] [Related]  

  • 45. Oxaliplatin induced-neuropathy in digestive tumors.
    Sereno M; Gutiérrez-Gutiérrez G; Gómez-Raposo C; López-Gómez M; Merino-Salvador M; Tébar FZ; Rodriguez-Antona C; Casado E
    Crit Rev Oncol Hematol; 2014 Jan; 89(1):166-78. PubMed ID: 24029604
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies.
    Chaudhry V; Rowinsky EK; Sartorius SE; Donehower RC; Cornblath DR
    Ann Neurol; 1994 Mar; 35(3):304-11. PubMed ID: 7907208
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [PSK decreased FOLFOX4-induced peripheral neuropathy and bone marrow suppression in patients with metastatic colorectal cancer].
    Shibata M; Shimura T; Nishina Y; Gonda K; Matsuo S; Abe H; Yajima Y; Nakamura I; Ohki S; Takenoshita S
    Gan To Kagaku Ryoho; 2011 May; 38(5):797-801. PubMed ID: 21566440
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Severe neuropathy after chemo- and radiotherapy of Ewing sarcoma].
    Lilje C; Sauter S; Hinkelbein W; Korinthenberg R; Niemeyer C
    Klin Padiatr; 1995; 207(4):204-6. PubMed ID: 7564152
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy.
    Stubblefield MD; McNeely ML; Alfano CM; Mayer DK
    Cancer; 2012 Apr; 118(8 Suppl):2250-60. PubMed ID: 22488699
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bortezomib-induced peripheral neuropathy in patients with multiple myeloma.
    Berkowitz A; Walker S
    Clin J Oncol Nurs; 2012 Feb; 16(1):86-9. PubMed ID: 22297012
    [TBL] [Abstract][Full Text] [Related]  

  • 51. NCCN guidelines for survivorship expanded to address two common conditions.
    Kvale E; Urba SG
    J Natl Compr Canc Netw; 2014 May; 12(5 Suppl):825-7. PubMed ID: 24853226
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A case of Paclitaxel-induced peripheral neuropathy successfully treated with duloxetine].
    Nagashima S; Kiba T; Ogawa Y; Mura T; Kajiume S; Okada Y; Morii N; Takahashi H; Ichiba Y; Yamashiro H
    Gan To Kagaku Ryoho; 2015 May; 42(5):617-9. PubMed ID: 25981658
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical and electrophysiological studies in vincristine induced neuropathy.
    Pal PK
    Electromyogr Clin Neurophysiol; 1999 Sep; 39(6):323-30. PubMed ID: 10499201
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Valproate protective effects on cisplatin-induced peripheral neuropathy: an in vitro and in vivo study.
    Rodriguez-Menendez V; Gilardini A; Bossi M; Canta A; Oggioni N; Carozzi V; Tremolizzo L; Cavaletti G
    Anticancer Res; 2008; 28(1A):335-42. PubMed ID: 18383866
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug-Induced Peripheral Neuropathy: Diagnosis and Management.
    Merheb D; Dib G; Zerdan MB; Nakib CE; Alame S; Assi HI
    Curr Cancer Drug Targets; 2022; 22(1):49-76. PubMed ID: 34288840
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy.
    Wen PY
    Clin Cancer Res; 2005 Mar; 11(5):1685-6. PubMed ID: 15755987
    [No Abstract]   [Full Text] [Related]  

  • 57. Understanding peripheral neuropathy in patients with cancer: background and patient assessment.
    Sweeney CW
    Clin J Oncol Nurs; 2002; 6(3):163-6. PubMed ID: 11998611
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cisplatin neurotoxicity.
    Cersosimo RJ
    Cancer Treat Rev; 1989 Dec; 16(4):195-211. PubMed ID: 2561592
    [No Abstract]   [Full Text] [Related]  

  • 59. Risk of chemotherapy-induced peripheral neuropathy in large population-based cohorts of elderly patients with breast, ovarian, and lung cancer.
    Nurgalieva Z; Xia R; Liu CC; Burau K; Hardy D; Du XL
    Am J Ther; 2010; 17(2):148-58. PubMed ID: 19417586
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed patients with multiple myeloma: subanalysis of the phase 3 VISTA study.
    Dimopoulos MA; Mateos MV; Richardson PG; Schlag R; Khuageva NK; Shpilberg O; Kropff M; Spicka I; Palumbo A; Wu KL; Esseltine DL; Liu K; Deraedt W; Cakana A; Van De Velde H; San Miguel JF
    Eur J Haematol; 2011 Jan; 86(1):23-31. PubMed ID: 20874823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.